195 related articles for article (PubMed ID: 35505353)
21. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program.
Osborn DP; Hardoon S; Omar RZ; Holt RI; King M; Larsen J; Marston L; Morris RW; Nazareth I; Walters K; Petersen I
JAMA Psychiatry; 2015 Feb; 72(2):143-51. PubMed ID: 25536289
[TBL] [Abstract][Full Text] [Related]
22. Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study.
Warren-Gash C; Davidson JA; Strongman H; Herrett E; Smeeth L; Breuer J; Banerjee A
Lancet Reg Health Eur; 2023 Apr; 27():100604. PubMed ID: 36911072
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a new algorithm for improved cardiovascular risk prediction.
Hippisley-Cox J; Coupland CAC; Bafadhel M; Russell REK; Sheikh A; Brindle P; Channon KM
Nat Med; 2024 May; 30(5):1440-1447. PubMed ID: 38637635
[TBL] [Abstract][Full Text] [Related]
24. QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
Amegadzie JE; Gao Z; Quint JK; Russell R; Hurst JR; Lee TY; Sin DD; Chen W; Bafadhel M; Sadatsafavi M
Thorax; 2023 Nov; ():. PubMed ID: 38050168
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings.
Dziopa K; Asselbergs FW; Gratton J; Chaturvedi N; Schmidt AF
Diabetologia; 2022 Apr; 65(4):644-656. PubMed ID: 35032176
[TBL] [Abstract][Full Text] [Related]
26. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
Polo Y la Borda J; Castañeda S; Sánchez-Alonso F; Plaza Z; García-Gómez C; Ferraz-Amaro I; Erausquin C; Valls-García R; Fábregas MD; Delgado-Frías E; Mas AJ; González-Juanatey C; Llorca J; González-Gay MA;
Semin Arthritis Rheum; 2024 Jun; 66():152442. PubMed ID: 38555727
[TBL] [Abstract][Full Text] [Related]
27. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.
Sun L; Pennells L; Kaptoge S; Nelson CP; Ritchie SC; Abraham G; Arnold M; Bell S; Bolton T; Burgess S; Dudbridge F; Guo Q; Sofianopoulou E; Stevens D; Thompson JR; Butterworth AS; Wood A; Danesh J; Samani NJ; Inouye M; Di Angelantonio E
PLoS Med; 2021 Jan; 18(1):e1003498. PubMed ID: 33444330
[TBL] [Abstract][Full Text] [Related]
28. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
[TBL] [Abstract][Full Text] [Related]
29. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
[TBL] [Abstract][Full Text] [Related]
30. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
31. Cross-sectional analysis of educational inequalities in primary prevention statin use in UK Biobank.
Carter AR; Gill D; Davey Smith G; Taylor AE; Davies NM; Howe LD
Heart; 2022 Apr; 108(7):536-542. PubMed ID: 34315717
[TBL] [Abstract][Full Text] [Related]
32. Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.
Sivakumaran J; Harvey P; Omar A; Tayer-Shifman O; Urowitz MB; Gladman DD; Anderson N; Su J; Touma Z
Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 34045359
[TBL] [Abstract][Full Text] [Related]
33. Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
van Staa TP; Gulliford M; Ng ES; Goldacre B; Smeeth L
PLoS One; 2014; 9(10):e106455. PubMed ID: 25271417
[TBL] [Abstract][Full Text] [Related]
34. The predictive accuracy of cardiovascular risk prediction tools in inflammatory arthritis and psoriasis: an observational validation study using the Clinical Practice Research Datalink.
Hughes DM; Coronado JIC; Schofield P; Yiu ZZN; Zhao SS
Rheumatology (Oxford); 2023 Nov; ():. PubMed ID: 37966910
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of metabolic profiling in cardiovascular risk scores: analysis of 75 000 adults in UK Biobank.
Jin D; Trichia E; Islam N; Lewington S; Lacey B
J Epidemiol Community Health; 2023 Dec; 77(12):802-808. PubMed ID: 37699667
[TBL] [Abstract][Full Text] [Related]
36. Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease.
Li Y; Sperrin M; Martin GP; Ashcroft DM; van Staa TP
Int J Med Inform; 2020 Jan; 133():104033. PubMed ID: 31785526
[TBL] [Abstract][Full Text] [Related]
37. Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration.
McGinnis KA; Justice AC; Marconi VC; Rodriguez-Barradas MC; Hauser RG; Oursler KK; Brown ST; Bryant KJ; Tate JP;
Front Med (Lausanne); 2023; 10():1342466. PubMed ID: 38356736
[TBL] [Abstract][Full Text] [Related]
38. The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.
Pate A; Emsley R; Ashcroft DM; Brown B; van Staa T
BMC Med; 2019 Jul; 17(1):134. PubMed ID: 31311543
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.
Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
RMD Open; 2023 Nov; 9(4):. PubMed ID: 38016710
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
